Oxcarbazepine exerts its pharmacological effects primarily through its main active metabolite, 10-monohydroxy derivative (MHD), also known as 10-hydroxycarbamazepine. This metabolite is the core substance responsible for the therapeutic action of oxcarbazepine.

AccuSift provides high-performance competitive antibody pairs for the detection of this oxcarbazepine metabolite. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 2 ng/mL